Sterling Capital Management’s Minerva Neurosciences NERV Stock Holding History

Sterling Capital Management’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64K	Buy	+296	New	+$1.6K	﹤0.01%	3043
2017 Q4	–	Sell	-6,517	Closed	-$396K	–	927
2017 Q3	$396K	Buy	6,517 +1,310	+25%	+$75.1K	﹤0.01%	797
2017 Q2	$369K	Buy	5,207 +3,311	+175%	+$214K	﹤0.01%	807
2017 Q1	$123K	Hold	1,896	–	–	﹤0.01%	935
2016 Q4	$178K	Sell	1,896 -959	-34%	-$97.9K	﹤0.01%	918
2016 Q3	$322K	Buy	2,855 +1,153	+68%	+$112K	﹤0.01%	797
2016 Q2	$139K	Buy	1,702 +452	+36%	+$28.7K	﹤0.01%	894
2016 Q1	$61K	Hold	1,250	–	–	﹤0.01%	896
2015 Q4	$61K	Buy	+1,250	New	+$52.2K	﹤0.01%	971

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's NERV Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 296 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #3043 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in NERV as recently as Q3 2017.

Sterling Capital Management first reported a position in NERV in Q4 2015 and has held it in 9 quarters since. The position peaked at $396K in Q3 2017. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

Sterling Capital Management held 296 shares of Minerva Neurosciences worth $1.64K as of Q2 2026.
Minerva Neurosciences was a new Sterling Capital Management position in Q2 2026.
Minerva Neurosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3043 holding.
Sterling Capital Management first reported a position in Minerva Neurosciences in Q4 2015 and has held it in 9 quarters since.
Sterling Capital Management's Minerva Neurosciences position peaked at $396K in Q3 2017.
60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.